Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H17N5O3 |
| Molecular Weight | 267.2844 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(CCO)C1=NC2=C(N1C)C(=O)N(C)C(=O)N2C
InChI
InChIKey=ZGNRRVAPHPANFI-UHFFFAOYSA-N
InChI=1S/C11H17N5O3/c1-13(5-6-17)10-12-8-7(14(10)2)9(18)16(4)11(19)15(8)3/h17H,5-6H2,1-4H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3913153
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3913153
Cafaminol, a nasal decongestant, has been used in the treatment of acute rhinitis in Germany.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Use of the preparation Cafaminol in the treatment of acute rhinitis]. | 1985-10-15 |
|
| [Human pharmacologic studies on the biologic availability and resorption of cafaminol (AWD) (proceedings)]. | 1979-05-01 |
|
| [A new treatment for colds using a new caffeine derivative, methylcoffanolamine]. | 1969-04-01 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
30924-31-3
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
C76089
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
3834
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104570
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
DTXSID60184916
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
Cafaminol
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
0L1S25NC1L
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
35685
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
m1051
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | Merck Index | ||
|
250-390-3
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
3059
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
C022126
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
SUB06043MIG
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY | |||
|
100000081590
Created by
admin on Mon Mar 31 18:21:49 GMT 2025 , Edited by admin on Mon Mar 31 18:21:49 GMT 2025
|
PRIMARY |
ACTIVE MOIETY